http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107531738-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-007 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-675 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-048 |
| filingDate | 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107531738-B |
| titleOfInvention | Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and uses thereof |
| abstract | Nicotinic acid riboside (NAR), nicotinamide riboside (NR), and derivatives of reduced NAR and NR (including 1-(2',3', 5'-triacetyl-β-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a)) and reduced derivative forms containing it and/or nicotinamide riboside (including 1-(2' , 3',5'-triacetyl-β-D-ribofuranosyl)-1,4-nicotinamide (2)). In some embodiments, the present invention relates to pharmaceutical and cosmetic compositions containing one or more NR, NAR, NRH or NARH derivatives or prodrugs or salts thereof. In other embodiments, the present invention relates to the use of one or more NR, NAR, NRH or NARH derivatives or prodrugs, solvates or salts thereof to promote nicotinamide adenine dinucleotide (NAD+) in cells and tissues A method of increasing intracellular levels of TM to improve cell and tissue survival and overall cell and tissue health. |
| priorityDate | 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 246.